Cargando…
Clinically Applicable Inhibitors Impacting Genome Stability
Advances in technology have facilitated the molecular profiling (genomic and transcriptomic) of tumours, and has led to improved stratification of patients and the individualisation of treatment regimes. To fully realize the potential of truly personalised treatment options, we need targeted therapi...
Autores principales: | Prakash, Anu, Garcia-Moreno, Juan F., Brown, James A. L., Bourke, Emer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100577/ https://www.ncbi.nlm.nih.gov/pubmed/29757235 http://dx.doi.org/10.3390/molecules23051166 |
Ejemplares similares
-
Targeting cancer using KAT inhibitors to mimic lethal knockouts
por: Brown, James A.L., et al.
Publicado: (2016) -
Rational design and validation of a Tip60 histone acetyltransferase inhibitor
por: Gao, Chunxia, et al.
Publicado: (2014) -
Centrosome amplification promotes cell invasion via cell–cell contact disruption and Rap-1 activation
por: Prakash, Anu, et al.
Publicado: (2023) -
Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability
por: Fu, Xuemei, et al.
Publicado: (2012) -
Clinical applications of Genome Polymorphism Scans
por: Weber, James L
Publicado: (2006)